Entera Bio Reports Positive PK Data for First-in-Class Oral GLP-2 Tablet Treatment for Patients with Short Bowel Syndrome at the 2025 ESPEN Congress

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and protein replacement therapies,

Intuitive Venture PartnersSeptember 15, 2025entera bio, 2025

Deep Fission Nuclear Completes $30M Financing in a Go-Public Transaction

Deep Fission, Inc. (“Deep Fission” or the “Company”), a pioneering advanced nuclear energy company placing small modular pressurized water reactors in

Intuitive Venture PartnersSeptember 9, 20252025, Deep Fission

Entera Bio Presents Positive Effects of EB613 on Both Trabecular and Cortical Bone in Postmenopausal Women with Osteoporosis at ASBMR 2025

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement

Intuitive Venture PartnersSeptember 8, 20252025, entera bio

Aeluma Appoints Industry Veteran Christopher Stewart as Chief Financial Officer

Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies

Intuitive Venture PartnersAugust 4, 20252025, Aeluma

Patero and Eridan Pioneer Quantum-Secure Open Radio Area Network

Patero, a leader in post-quantum cryptography, and Eridan, a pioneer in Open Radio Access Network (Open RAN) technology, today announced the

Intuitive Venture PartnersAugust 4, 20252025, eridan

Entera Bio Receives FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study in Post-Menopausal Women with Osteoporosis

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral

Intuitive Venture PartnersJuly 28, 20252025, entera bio

Global Nuclear Waste Disposal Innovator Deep Isolation Announces Go-Public Transaction and Oversubscribed $33 Million Financing

Deep Isolation Nuclear, Inc., a leading innovator in nuclear waste disposal technology, announced that on

Intuitive Venture PartnersJuly 24, 20252025, Deep Isolation

Aeluma CEO to Co-Chair Optica 2025 Advanced Photonics Congress Industry Program

Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies

Intuitive Venture PartnersJuly 15, 20252025, aeluma

Saab Chooses Anduril Rocket Motor Systems to Design and Produce Solid Rocket Motors

Saab, Inc. has selected Anduril Rocket Motor Systems as a supplier to design, develop, qualify, and eventually produce

Intuitive Venture PartnersJune 21, 20252025, anduril

Aeluma Wins Funding from the Navy to Accelerate Development and Commercialization of High-Speed Photodetectors for Optical Interconnects

Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies,

Intuitive Venture PartnersJune 16, 20252025, aeluma

Anduril and Meta Team Up to Transform XR for the American Military

Anduril and Meta are partnering to design, build, and field a range of integrated XR products that provide warfighters

Intuitive Venture PartnersMay 29, 20252025, Anduril

Aeluma and Thorlabs Unveil Breakthrough with Large-Diameter Wafer Manufacturing Platform for Quantum Computing and Communication

Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies, together with Thorlabs

Intuitive Venture PartnersMay 29, 2025aeluma, 2025

Aeluma Receives U.S. Department of Energy Contract for Scalable Semiconductor Sensors

Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies

Intuitive Venture PartnersApril 23, 2025aeluma, 2025

Special Operations Command Selects Anduril as Mission Autonomy Systems Integration Partner

United States Special Operations Command (USSOCOM) has awarded Anduril a three-year,

Intuitive Venture PartnersMarch 27, 20252025, Anduril

Aeluma Announces Nasdaq Uplisting and Pricing of $12 Million Public Offering

Aeluma, Inc. (OTCQB:ALMU) ("Aeluma" or "the Company"), a semiconductor company specializing in

Intuitive Venture PartnersMarch 27, 20252025, Aeluma

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, entered into a

Intuitive Venture PartnersMarch 17, 20252025, entera bio

Aeluma to Showcase Next-Generation Sensor and Silicon Photonic Solutions at SPIE Defense + Commercial Sensing

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in high performance, scalable technologies for mobile, automotive, AI, defense and

Intuitive Venture PartnersMarch 10, 20252025, Aeluma

Aeluma Appoints Former NVIDIA Finance Leader Mike Byron to Board of Directors

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in high performance, scalable technologies for